Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advanced refractory polymyositis responding to infliximab.

Literature DB >> 15695299

Advanced refractory polymyositis responding to infliximab.

A Anandacoomarasamy, G Howe, N Manolios.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 15695299 DOI： 10.1093/rheumatology/keh539

Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.

Authors: Siamak Moghadam-Kia; Rohit Aggarwal; Chester V Oddis
Journal: Expert Rev Clin Immunol Date: 2015-08-27 Impact factor: 4.473

2. Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.

Authors: Paola Caramaschi; Alessandro Volpe; Antonio Carletto; Lisa M Bambara; Domenico Biasi
Journal: Clin Rheumatol Date: 2007-01-17 Impact factor: 2.980

Review 3. [Current treatments of dermatomyositis and polymyositis].

Authors: J Richter; C Iking-Konert
Journal: Z Rheumatol Date: 2007-12 Impact factor: 1.372

Review 4. Treatment in myositis.

Authors: Chester V Oddis; Rohit Aggarwal
Journal: Nat Rev Rheumatol Date: 2018-03-29 Impact factor: 20.543

5. Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab.

Authors: Jin-Kyoung Park; Han-Gyul Yoo; Dae-Seon Ahn; Hyun-Soon Jeon; Wan-Hee Yoo
Journal: Rheumatol Int Date: 2011-11-17 Impact factor: 2.631

Review 10. Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.

Authors: Ilaria Pagnini; Antonio Vitale; Carlo Selmi; Rolando Cimaz; Luca Cantarini
Journal: Clin Rev Allergy Immunol Date: 2017-02 Impact factor: 10.817

Advanced refractory polymyositis responding to infliximab.

Review 1. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.

2. Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.

Review 3. [Current treatments of dermatomyositis and polymyositis].

Review 4. Treatment in myositis.

5. Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab.

Review 6. Abatacept as a successful therapy for myositis—a case-based review.

Review 7. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

Review 8. Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

9. Treatment of early and refractory dermatomyositis with infliximab: a report of two cases.

Review 10. Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.